bone morphogenetic protein receptor type 1A
Last updated 18 Aug 2020
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The BMPR1A gene provides instructions for making a protein called bone morphogenetic protein receptor 1A. This receptor protein has a specific site into which certain other proteins, called ligands, fit like keys into locks. Specifically, the BMPR1A protein attaches (binds) to ligands in the transforming growth factor beta (TGF-β) pathway. This signaling pathway allows the environment outside the cell to affect how the cell produces other proteins. The BMPR1A receptor protein and its ligands are involved in transmitting chemical signals from the cell membrane to the nucleus.
Video picks for GenesVideo library
Normal function
The BMPR1A gene provides instructions for making a protein called bone morphogenetic protein receptor 1A. This receptor protein has a specific site into which certain other proteins, called ligands, fit like keys into locks. Specifically, the BMPR1A protein attaches (binds) to ligands in the transforming growth factor beta (TGF-β) pathway. This signaling pathway allows the environment outside the cell to affect how the cell produces other proteins. The BMPR1A receptor protein and its ligands are involved in transmitting chemical signals from the cell membrane to the nucleus.
When the BMPR1A protein is bound to a ligand, it turns on (activates) a group of related proteins (a protein complex) called SMAD proteins. The activated SMAD protein complex is then transported into the cell's nucleus, where it regulates cell growth and division (proliferation) and the activity of particular genes.
Conditions referring to this gene or chromosome
Other names
activin A receptor, type II-like kinase 3
ACVRLK3
ALK3
BMR1A_HUMAN
bone morphogenetic protein receptor type IA
bone morphogenetic protein receptor, type IA
bone morphogenetic protein receptor, type IA precursor
CD292
serine/threonine-protein kinase receptor R5
SKR5
Patient picks for Genes

Diet and nutrition
10 sources of plant-based protein for bone health
Plant-based diets are growing in popularity. People choose this way of eating for various reasons - to boost their health, help animals, and protect the environment. But switching to a plant-based diet may mean you're missing out on vital, bone-friendly nutrients. One of these is protein.
by Victoria Raw

Tests and investigations
Bone scan
A bone scan is a special type of nuclear medicine procedure that uses radionuclides to create a picture of the bones. Radionuclides are chemicals which emit radioactivity that can be detected by special scanners. A bone scan is different to a bone density scan (DEXA). See the DEXA Scan leaflet for more information on this bone density test. A DEXA scan is also known as a DXA scan. Note: the information below is a general guide only. The arrangements, and the way tests are performed, may vary between different hospitals. Always follow the instructions given by your doctor or local hospital.
by Dr Doug McKechnie, MRCGP

Diabetes
MHRA approves teplizumab to delay progression of type 1 diabetes
Teplizumab (Tzield) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to help delay the onset of Stage 3 type 1 diabetes (T1D). Read on to see what this means if you are prescribed teplizumab and what it does for you.
by Lawrence Higgins

Diet and nutrition
Plant-based proteins could help prevent high blood pressure
Eating a greater amount of minimally processed plant-based proteins - such as beans, nuts and lentils - may lower your chance of developing high blood pressure, according to new research.
by Laura Williamson

Cancer
Paget's disease of bone
Paget's disease of bone affects the structure of parts of one or more bones. In most cases it causes no symptoms and does not need treatment. Symptoms develop in some cases and pain in the affected part of bone is the most common symptom. Affected bones are weaker than normal and may become deformed and may break (fracture) more easily than normal. Treatment with a bisphosphonate medicine is used in some cases to ease pain and to help treat complications.
by Dr Colin Tidy, MRCGP

Kidney and urinary tract
Proteinuria
Proteins are molecules that are found in almost every part of the body, including in the blood. The kidneys normally have a filter which stops protein from entering the urine, except in very tiny amounts; however, kidney problems can cause higher levels of protein to be found in the urine.
by Dr Doug McKechnie, MRCGP
Related patient information and medicines

Patient information leaflet
Breast cancer
...inoma in situ (or non-invasive breast cancer), as no cancerSometimes a biopsy of an obvious lump is arranged, but other tests may be done first. [https://patient.info/health/breast-cancer-leaflet](https://patient.info/health/breast-cancer-leaflet) Dr Krishna Vakharia , 16th October 2023 The National Institute for Health and Care Excellence.

Patient information leaflet
Throat cancer
It is sometimes called laryngeal cancer (cancer of the larynx). (The throat is usually sprayed with a local anae... Dr Krishna Vakharia, 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a diagnosis or ruling out of cancer within 28 days of being referred urgently by their.

Patient information leaflet
Blood groups and types
ABO and rhesus are both types of antigens found on the surface of red blood cells. There are lots of other types but these are the most important. The main reasons to know your blood group are if you need to have a blood transfusion or if you are pregnant. What is a blood group. Red blood cells (erythrocytes) have certain proteins on their.

Patient information leaflet
Bone scan
A bone scan is a special type of nuclear medicine procedure that uses radionuclides to create a picture of the bones. Radionuclides are chemicals which emit radioactivity that can be detected by special scanners. A bone scan is different to a bone density scan (DEXA). See the DEXA Scan leaflet for more information on this bone density test. A DEXA.

Patient information leaflet
Diabetic kidney disease
Diabetic kidney disease is actually the most co... Note : most people with diabetes do not need dialysis. For people with type 1 diabetes Roughly 1 in 10 people with diabetes have type 1 diabetes. Type 1 diabetes is an autoimmune condition where the body's immune system destroys the cells that make insulin. It usually begins in childhood or.

Patient information leaflet
Can I take Candesartan and Collagen together?
There are no known sign... It is generally considered safe to take these together. Why this happens Candesartan is a blood pressure medication (an angiotensin II receptor blocker) that works on the hormonal system controlling blood vessels. Collagen is a protein supplement used for skin, joint, and bone health. These two substances are processed.
Further reading and references
- bone morphogenetic protein receptor type 1A; MedlinePlus, National Library of Medicine.
- Aretz S, Stienen D, Uhlhaas S, Stolte M, Entius MM, Loff S, Back W, Kaufmann A, Keller KM, Blaas SH, Siebert R, Vogt S, Spranger S, Holinski-Feder E, Sunde L, Propping P, Friedl W. High proportion of large genomic deletions and a genotype phenotype update in 80 unrelated families with juvenile polyposis syndrome. J Med Genet. 2007 Nov;44(11):702-9. doi: 10.1136/jmg.2007.052506. Epub 2007 Sep 14.
- Calva-Cerqueira D, Chinnathambi S, Pechman B, Bair J, Larsen-Haidle J, Howe JR. The rate of germline mutations and large deletions of SMAD4 and BMPR1A in juvenile polyposis. Clin Genet. 2009 Jan;75(1):79-85. doi: 10.1111/j.1399-0004.2008.01091.x. Epub 2008 Sep 24.
- Howe JR, Bair JL, Sayed MG, Anderson ME, Mitros FA, Petersen GM, Velculescu VE, Traverso G, Vogelstein B. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet. 2001 Jun;28(2):184-7. doi: 10.1038/88919.
- Howe JR, Sayed MG, Ahmed AF, Ringold J, Larsen-Haidle J, Merg A, Mitros FA, Vaccaro CA, Petersen GM, Giardiello FM, Tinley ST, Aaltonen LA, Lynch HT. The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations. J Med Genet. 2004 Jul;41(7):484-91. doi: 10.1136/jmg.2004.018598.
- Pyatt RE, Pilarski R, Prior TW. Mutation screening in juvenile polyposis syndrome. J Mol Diagn. 2006 Feb;8(1):84-8. doi: 10.2353/jmoldx.2006.050072.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

